|
Business Development
Kowa Research Institute has a strong pipeline of innovative and novel products for:
| |
 |
Cardiovascular Disease |
| |
|
Metabolic Disease |
| |
|
Peripheral Arterial Disease |
| |
|
Pain Management |
Kowa’s strategy is to develop these novel compounds through proof of concept and, in selected cases, identify ideal partners for:
| |
|
Co-development |
| |
|
Co-commercialization |
| |
|
Licensing |
The Company also considers compelling partnerships at earlier stages. If you are interested in discussing any business development opportunity, please contact:
Gary Gordon, M.B.A., M.D.
SVP, Operations
ggordon@kowaus.com
Kowa Research Institute, Inc.
430 Davis Drive, Suite 200
Morrisville, NC 27560 USA
Phone: +1-919-433-1600
Fax: +1-919-433-1620
|
